A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MACE / major adverse cardiac events

[Related PubMed/MEDLINE]
Total Number of Papers: 5165
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MACE  (>> Co-occurring Abbreviation)
Long Form:   major adverse cardiac events
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry. ADVANCE, CI, CTA, FFRCT, MI, RR
2020 12-Month clinical outcomes of amphilimus drug eluting stents in an all-comers South-East Asian registry. AES, MI, TLR
2020 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques. LCBI, LRP, NIRS, PCI
2020 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). ADA, CKD, CVD, EASD, GLP-1, HHF, SGLT2
2020 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). ADA, CKD, CVD, EASD, GLP-1, HHF, SGLT2
2020 5-Year Prognostic Value of QuantitativeVersus Visual MPI in SubtlePerfusionDefects: Results From REFINE SPECT. CI, HR, SPECT, TPD
2020 60-day major adverse cardiac events in emergency department patients with non-low modified HEART scores. ECGs, HEART
2020 A 90-second magnetocardiogram using a novel analysis system to assess for coronary artery stenosis in Emergency department observation unit chest pain patients. ACS, CA, CAS, ED, MCG, OU, ST
2020 A Call for a New Paradigm for Diabetes Care in the Era of Sodium-Glucose Cotransporter2 Inhibitors (SGLT2i). SGLT2i
10  2020 A comparison of contemporary versus older studies of aspirin for primary prevention. CI, IPD, MI
11  2020 A Coronary Artery Calcium Score of Zero in Patients Who Have Undergone Coronary Computed Tomography Angiography Is Associated With Freedom From Major Adverse Cardiovascular Events. CACS, CAD, CCTA
12  2020 A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism. CKD, CKD-EPI, CVD, DPN, DR, eGFR
13  2020 A large-scale cohort study of long-term cardiac rehabilitation: A prospective cross-sectional study. CR
14  2020 A meta-analysis of efficacy and safety of genotype-guided versus standard of care treatment strategies in selecting antiplatelet therapy in patients with acute coronary syndrome. ACS, CIs, CV, GGT, MI, ORs, SCT
15  2020 A neurobiological mechanism linking transportation noise to cardiovascular disease in humans. AmygA, ArtI, CVD
16  2020 A Novel Index for Prompt Prediction of Severity in Patients with Unstable Angina Pectoris. ED, m-HS, PLR, UAP
17  2020 A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation. AF
18  2020 Achilles tendon thickening is associated with higher incidence of adverse cardiovascular event in patients with coronary artery disease. ATT, CAD, PCI, TVR
19  2020 Active Participation in Outpatient Cardiac Rehabilitation Is Associated With Better Prognosis After Coronary Artery Bypass Graft Surgery - J-REHAB CABG Study. CABG, CR
20  2020 Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study. DPP-4, GLP-1RAs, HF, HR, MI, SGLT2, SU, T2D
21  2020 Added value of high-risk plaque criteria by coronary CTA for prediction of long-term outcomes. CAD, CCS, CTA, HRP, LAP, NCP
22  2020 Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China. CVD, PDC
23  2020 Age and diabetes mellitus associated with worse outcomes after percutaneous coronary intervention in a multi-ethnic Asian dialysis patient population. AMI, CI, LVEF, OR, PCI
24  2020 An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data. DMARD, HZ, IRs, NMSC, PsA
25  2020 Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers (ACEI/ARB) are Associated with Improved Limb Salvage after Infrapopliteal Interventions for Critical Limb Ischemia. CLI, LS, PAD, PP, SP
26  2020 Annulus root enlargement during redo aortic valve replacement: Perioperative results and hemodynamic impact. ARE, AVR, PPM
27  2020 Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia. ACS, AMPs, DAPT, MI, NSTEMI, PCI, STEMI, UA
28  2020 Antithrombotic therapy for chronic coronary syndrome and atrial fibrillation: less might be more. AF, MI, OAC, RR
29  2020 Antithrombotic Therapy for Patients With Left Ventricular Mural Thrombus. CI, HR, LVT
30  2020 Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis. ATT, CI, NSTE-ACS, OR
31  2020 Antithrombotic treatment and major adverse cardiac events after bleeding in patients with myocardial infarction: a retrospective analysis of nationwide registry data. MI, VKA
32  2020 Apabetalone -BET protein inhibition in cardiovascular disease and Type 2 diabetes. CVD, T2D
33  2020 Application of a machine learning-driven, multibiomarker panel for prediction of incident cardiovascular events in patients with suspected myocardial infarction. MI
34  2020 Application of blood pre-albumin and NT-pro BNP levels in evaluating prognosis of elderly chronic heart failure patients. CHF, CI, NT-pro-BNP, OR, PA
35  2020 Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation? AF, AHREs
36  2020 Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification. CV
37  2020 Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis. CI, RCTs, RR
38  2020 Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties. ACB, HR
39  2020 Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials. CV, HHF, PIO
40  2020 Assessment of Growth Differentiation Factor 15 Levels on Coronary Flow in Patients with STEMI Undergoing Primary PCI. GDF15, TIMI
41  2020 Assessment of Sex Differences in 5-Year Clinical Outcomes Following Endovascular Revascularization for Peripheral Artery Disease. MALE, PAD, PSM, PTA
42  2020 Association Between an Acute, Drug-Induced Decrease in High-Density Lipoprotein Cholesterol Levels and Risk of Cardiovascular Events. CI, CPRD, CV, HDL-C, HR
43  2020 Association between antecedent blood pressure, hypertension-mediated organ damage and cardiovascular outcome. HMOD, SBP
44  2020 Association between anxiety and clinical outcomes in Chinese patients with myocardial infarction in the absence of obstructive coronary artery disease. AMI, CAD, CI, HR, MINOCA
45  2020 Association between ceramides and coronary artery stenosis in patients with coronary artery disease. ACS, AMI, AUC, ROC
46  2020 Association between circulating proprotein convertase subtilisin/kexin type 9 levels and prognosis in patients with severe chronic kidney disease. CAD, CCTA, ICA, LDL-C, PCSK9
47  2020 Association Between Hemoglobin A1c and Major Adverse Coronary Events in Patients with Diabetes Following Coronary Artery Bypass Surgery. BARI 2D, CABG, HbA1c, HRs
48  2020 Association between history of cancer and major adverse cardiovascular events in patients with chest pain presenting to the emergency department: a secondary analysis of a prospective cohort study. CI, ED, OR
49  2020 Association between inflammatory cytokines and long-term adverse outcomes in acute coronary syndromes: A systematic review. ACS
50  2020 Association between mean platelet volume and major adverse cardiac events in percutaneous coronary interventions: a systematic review and meta-analysis. MPV, PCI, USMD
51  2020 Association between metabolic surgery and cardiovascular outcome in patients with hypertension: A nationwide matched cohort study. ACS, BMI, CIs, HR, NPR
52  2020 Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study. CLTI, MALE, PAD, ROC, T2DM
53  2020 Association between Preoperative Nutritional Status and Clinical Outcomes of Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. AMI, CAD, CHF, CONUT, CV, HR, MI, PCI
54  2020 Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate. ACEI, ARB, eGFR, ESKD, HR
55  2020 Association between Statins Prescribed for Primary and Secondary Prevention and Major Adverse Cardiac Events among Older Adults with Frailty: A Systematic Review. CI, HR
56  2020 Association between Tpeak-Tend/QT and major adverse cardiovascular events in patients with Takotsubo syndrome. Tp-e, TTS
57  2020 Association between Variation of Troponin and Prognosis of Acute Myocardial Infarction before and after Primary Percutaneous Coronary Intervention. AUC, CI, cTnI, HR, PPCI, ROC, STEMI
58  2020 Association of Biomarker Level with Cardiovascular Events: Results of a 4-Year Follow-Up Study. CE, CVD, H-FABP
59  2020 Association of change in alcohol consumption with cardiovascular disease and mortality among initial nondrinkers. HRs
60  2020 Association of Controlling Nutritional Status Score With 2-Year Clinical Outcomes in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. CI, CONUT, PPCI, STEMI
61  2020 Association of Dysfunction of Vascular Access for Hemodialysis With Major Adverse Cardiovascular Events - A Group-Based Trajectory Model Analysis. ---
62  2020 Association of ECG parameters with late gadolinium enhancement and outcome in patients with clinical suspicion of acute or subacute myocarditis referred for CMR imaging. CMR, ECG
63  2020 Association of gout with major adverse cardiovascular events and all-cause mortality in patients with peripheral artery disease. PAD
64  2020 Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. CTA, HR
65  2020 Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial. ACS, HDL-C, HDL-P
66  2020 Association of Hyperhomocysteinemia with Increased Coronary Microcirculatory Resistance and Poor Short-Term Prognosis of Patients with Acute Myocardial Infarction after Elective Percutaneous Coronary Intervention. AMI, HHcy, IMR, IRV, LVEDD, LVEF, PCI
67  2020 Association of lymphocyte-to-monocyte ratio with the long-term outcome after hospital discharge in patients with ST-elevation myocardial infarction: a retrospective cohort study. CI, HR, LMR, STEMI
68  2020 Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort. ARIC, SNPs
69  2020 Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD. DRKS, GCKD, HR
70  2020 Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. ACS, aHR, PCI
71  2020 Associationbetween admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction. AMI, CI, GAM, SBP
72  2020 Associations between serum potassium and adverse clinical outcomes: A systematic literature review. CKD, HF, HK, RAASi
73  2020 Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition. CAD, CANTOS, CIRT, CRP, hs-CRP, IL-1ss, MI, NLRP3
74  2020 Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices. AHREs, CI, CIEDs, IR
75  2020 Atrioventricular mechanical coupling and major adverse cardiac events in female patients following acute ST elevation myocardial infarction. CMR, LVEF, MI
76  2020 Automated quantitative analysis of CZT SPECT stratifies cardiovascular risk in the obese population: Analysis of the REFINE SPECT registry. BMI, MPI, TPD
77  2020 Average pixel intensity method for prediction of outcome in secondary mitral regurgitation. API, PISA, SMR
78  2020 Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial. DCB, NSTEMI, TLF
79  2020 Baroreflex sensitivity but not microvolt T-wave alternans can predict major adverse cardiac events in ischemic heart failure. ANS, BRS, HF, HRV, LVEF, MTWA
80  2020 Baseline LV ejection fraction by cardiac magnetic resonance and 2D echocardiography after ST-elevation myocardial infarction - influence of infarct location and prognostic impact. 2DE, CMR, LVEF, STEMI
81  2020 Baseline, delta, and achieved low-density lipoprotein cholesterol levels and cardiovascular risk in patients on statin therapy: A post-hoc resampling mediation analysis of treating new targets [TNT] trial. CI, HRs, LDL-C, TNT
82  2020 Benefit of dual antithrombotic therapy with direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and metaanalysis of randomized clinical trials. ACS, CI, DAT, DOAC, OR, TAT, VKA
83  2020 Beta-blocker exposure for short-term outcomes following non-cardiac surgery: A meta-analysis of observational studies. ACM
84  2020 Biologic Agents Reduce Cardiovascular Events in Rheumatoid Arthritis Not Responsive to Tumour Necrosis Factor Inhibitors: A National Cohort Study. CI, CV, HR, RA, TNFis
85  2020 Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction. AUC, CT-proET-1, cTn, MR-proADM, MR-proANP, ROC, T1MI, T2MI
86  2020 Biomarkers of platelet activation and cardiovascular risk in the DAPT trial. DAPT, MRP, PCI, PRI, sCD40L
87  2020 Biometric and Psychometric Remote Monitoring and Cardiovascular Risk Biomarkers in Ischemic Heart Disease. ---
88  2020 Body Mass Index and Major Adverse Cardiovascular Events: A Secondary Analysis Based on a Retrospective Cohort Study. BMI, CAD, PCI, ROC
89  2020 Both baseline Selvester QRS score and change in QRS score predict prognosis in patients with acute ST-segment elevation myocardial infarction after percutaneous coronary intervention. HR, PCI, STEMI
90  2020 Branched Chain Amino Acids, Cardiometabolic Risk Factors and Outcomes in Older Men: The Concord Health and Ageing in Men Project. AABA, BCAAs, HOMA-IR
91  2020 Brief Report: Integrase Strand Transfer Inhibitors Are Associated With Lower Risk of Incident Cardiovascular Disease in People Living With HIV. ART, INSTI, MI, PLWH
92  2020 Cardiac Magnetic Resonance Feature Tracking Global Longitudinal Strain and Prognosis After Heart Transplantation. CMR-FT, GLS, LVEF
93  2020 Cardiac Magnetic Resonance Myocardial Feature Tracking for Optimized Risk Assessment After Acute Myocardial Infarction in Patients With Type 2 Diabetes. AMI, CMR, GLS, LA, LV, LVEF
94  2020 Cardiac rehabilitation and 5-year mortality after acute myocardial infarction. Report from 11 tertiary hospitals in Korea (ETHIK Study). AMI, CR, HR
95  2020 Cardioprotective medication adherence in Western Australians in the first year after myocardial infarction: restricted cubic spline analysis of adherence-outcome relationships. MI, RASI, RCS
96  2020 Cardiotoxicity evaluation using magnetic resonance imaging in breast Cancer patients (CareBest): study protocol for a prospective trial. ECV, EF, LV, MRI
97  2020 Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial. CVD/HHF, HRs, MI
98  2020 Cardiovascular Effects of CAR T Cell Therapy: A Retrospective Study. CAR, CRS
99  2020 Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis. CIs, CV, RCTs, RRs, ULTs, XOIs
100  2020 Cardiovascular events prediction by left ventricular longitudinal strain and serum high-sensitivity troponin I in patients with axial spondyloarthritis. CS, CV, hsTnI, LS, mSASSS, RS, SpA